Panacea Index Logo

Command Palette

Search for a command to run...

Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.

Clinical interventions in aging
January 1, 2023
Colin Tuft et al. (6 authors)
Journal ArticleReviewHuman Study
Extracted Claims (5)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Exogenous melatonin
neutral
sleep disorders
older adults
-
is commonly used for
#1
Exogenous melatonin
neutral
insomnia and circadian rhythm sleep-wake disorders
-
-
appears to have modest efficacy in treating
#2
Melatonin
neutral
a safe alternative to other hypnotics
-
-
is commonly perceived to be
#3
Endogenous melatonin
neutral
multiple organ systems
-
-
has pleomorphic effects on
#4
Melatonin
neutral
a favorable safety profile
older adults (defined by age over 65 years)
-
appears to have
#5
Abstract

Exogenous melatonin is commonly used for sleep disorders in older adults, and its use is increasing over time. It appears to have modest efficacy in treating insomnia and circadian rhythm sleep-wake disorders. Melatonin is commonly perceived to be a safe alternative to other hypnotics and is available without prescription in some jurisdictions. New evidence suggests that endogenous melatonin has pleomorphic effects on multiple organ systems, many of which are poorly understood. This narrative review summarizes the current evidence regarding the safety of melatonin in older adults (defined by age over 65 years). Melatonin appears to have a favorable safety profile in this population, however there is a dearth of evidence regarding the safety of prolonged use. There are several factors which increase the risk of adverse effects of melatonin in older adults, and these should be taken into consideration when prescribing to this population.

Medical Subject Headings (MeSH)
HumansAgedSleepMelatoninSleep Initiation and Maintenance DisordersHypnotics and SedativesSleep Wake DisordersCircadian RhythmSleep Disorders, Circadian Rhythm
Study Links
Citation Metrics
Total Citations21
Citations/Year10.5
Relative Citation Ratio5.86
NIH Percentile94.6%
Research Impact Scores
APT Score0.75
Related Supplements
Current Insights into the Risks of Using Melatonin as a Trea... | Panacea Index